Find Lawyers

Lawrence Sung is a registered patent attorney with a Ph.D in microbiology who has nearly 20 years of experience in biotechnology, medical device and pharmaceutical patent counseling, litigation and technology transfer. A former judicial clerk to (now Senior) Circuit Judge Raymond C. Clevenger III of the U.S. Court of Appeals for the Federal Circuit, Dr. Sung has also been involved extensively in patent appeals. In addition, he is a professor at the University of Maryland School of Law, where he is the director of the Intellectual Property Law Program. Dr. Sung has served as a consultant to the National Human Genome Research Institute and as a member of the National Academies Standing Committee on Emerging Issues and Data on Environmental Contaminants. He has also testified before the U.S. House of Representatives Committee on the Judiciary, Subcommittee on Courts, the Internet, and Intellectual Property, on the role of gene patents in research and genetic testing. He is a prolific speaker and has authored numerous publications, including three books on patent law.

Dr. Sung is a member of the American Bar Association and the American Intellectual Property Law Association. He is a past Chair for the Asian-Pacific American Bar Association of the District of Columbia Partners’ Forum and a past Chair of The National Research Council Committee on Intellectual Property Concerns for Toxicogenomics.

Recent Representations

• Lead Counsel, Capstone, S.G., Inc. v. U.S. Secret Service Uniformed Division Benefit Fund, No. 2011CA004942B (D.C. Super. Ct. 2012)
• Lead Counsel, McQueen v. Woodstream Corp., No. 10-7002 (D.C.Cir. 2010)
• Lead Counsel, McQueen v. Woodstream Corp., No. 1:05-cv-02068-RMU (D.D.C. 2010)
• Lead Counsel, Brief of Amicus Curiae Medtronic, Inc., in Support of Neither Party, Bilski v. Kappos, No. 08-964 (U.S. 2009)

Publications

• Author: “Part Five: Is it ethical to patent or copyright genes, embryos, or their parts?” Contemporary Debates In Bioethics (2012)
• Author: “Chapter 5: Infringement Liability, Products Liability, Risk Allocation, and the Transfer of University and Laboratory-Owned Technology,” 2012 Supplement to Intellectual Property Technology Transfer (2012)
• Author: 2012 Supplement to Patent Infringement Remedies, BNA Books (2012)
• Author: “Medical Alert: Alarming Challenges Facing Medical Technology Innovation,” 6 J. Bus. & Tech. L. 35 (2011)
• Author: Medical Device Patents, Thomson/West (2011)
• Co-Author with Jeff E. Schwartz: 2011-2012 Patent Law Handbook, Thomson/West (2011)

Speeches and Programs

• “Practical Patent Prosecution for New Lawyers—Biotechnology Claim Drafting,” American Intellectual Property Law Association (Alexandria, VA, August 2012)
• “Medical Device Patents, Protecting Diagnostic Method Claims post-Bilski: Lessons for Prosecutors and Litigators to Comply with Increasingly Strict Standards of Patentability,” American Conference Institute (Boston, MA, February 2012)
• “Patenting Biologics,” BioWorld Webinar (Washington, D.C., February 2012)  
• “Ethical Patenting,” DePaul University College of Law Edward D. Manzo Scholars in Patent Law Series (Chicago, IL, February 2012)
• “Biosimilar Patents: Effects of BPCIA and Hatch-Waxman,” BioWorld Webinar (Washington, D.C., December 2011)
• “Demystifying the Unique Legal and Regulatory Challenges in Entering into Early Stage Research Partnerships in Emerging Markets,” American Conference Institute, Life Sciences Business Development & Acquisitions (New York, NY, September 2011)
• “Practical Patent Prosecution for New Lawyers—Biotechnology and Claim Drafting,” American Intellectual Property Law Association (Alexandria, VA, August 2011)
• “Gene Patenting in the Wake of Myriad Genetics,” LexisNexis and Managing IP Event (Washington, DC, August 2011)
• “Biotechnology Patent Prosecution,” Asia Pacific Legal Institute 2011 Summer Intellectual Property Training Program (Washington, DC, July 2011)
• “Trends in Biosimilars and Implications for Licensing,” Licensing Executive Society 2011 Spring Meeting (New York, NY, May 2011)
• “Intellectual Property Concerns,” Frontiers in Stem Cells and Cancer Research (Washington, DC, March 2011)
• “The Threat of Intellectual Property Strategies,” VisionGain Biosimilars & Follow on Biologics Americas Conference (Boston, MA, March 2011)